In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Gets Closer to Customers

Executive Summary

Pfizer's decision to bypass UK wholesalers and go direct to pharmacies should ultimately give it better control over product discounting. Other manufacturers are watching closely, and not just in the UK.

You may also be interested in...



No Cure, No Pay: The Future of Drug Marketing?

For most other consumer goods, you'd expect to get your money back if the product didn't work. Not so for drugs, where many treatments don't work in at least a significant minority of patients--but payors and governments can't claim a refund. That may be about to change.

No Cure, No Pay: The Future of Drug Marketing?

For most other consumer goods, you'd expect to get your money back if the product didn't work. Not so for drugs, where many treatments don't work in at least a significant minority of patients--but payors and governments can't claim a refund. That may be about to change.

CEO Interview: AstraZeneca's David Brennan

David Brennan has sharpened AstraZeneca's therapeutic area focus and embraced external R&D. The next two years will determine whether the productivity drive is working--or if more radical change is needed.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

OM004514

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel